Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Therapies and Developing Precision Medicine in Gastric Cancer. | Cancers (Basel) | 2023 | 37370858 | PubTator, text mining | PubMed |
| Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven Approach. | Cancers (Basel) | 2023 | 37370767 | PubTator, text mining | PubMed |
| Target 2035 - an update on private sector contributions. | RSC Med Chem | 2023 | 37360399 | PubTator, text mining | PubMed |
| ZNF219, a novel transcriptional repressor, inhibits transcription of the prototype foamy virus by interacting with the viral LTR promoter. | Virus Res | 2023 | 37356580 | PubTator, text mining | PubMed |
| Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex. | Cancer Res | 2023 | 37352376 | PubTator, text mining | PubMed |
| Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence. | Mol Med | 2023 | 37344790 | PubTator, text mining | PubMed |
| Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology. | Medicine (Baltimore) | 2023 | 37335709 | PubTator, text mining | PubMed |
| Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011-2021. | Oncol Ther | 2023 | 37330972 | PubTator, text mining | PubMed |
| The Contributions of Trace Elements on Molecular Subtype-Specific Colorectal Cancer. | J Cancer | 2023 | 37325050 | PubTator, text mining | PubMed |
| Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers. | Int J Med Sci | 2023 | 37324191 | PubTator, text mining | PubMed |
| Nuclear translocation of an aminoacyl-tRNA synthetase may mediate a chronic "integrated stress response". | Cell Rep | 2023 | 37314928 | PubTator, text mining | PubMed |
| Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation? | Int J Mol Sci | 2023 | 37298731 | PubTator, text mining | PubMed |
| RNA-Binding Proteins and Their Emerging Roles in Cancer: Beyond the Tip of the Iceberg. | Int J Mol Sci | 2023 | 37298567 | PubTator, text mining | PubMed |
| HIF-1-Induced hsa-miR-429: Understanding Its Direct Targets as the Key to Developing Cancer Diagnostics and Therapies. | Cancers (Basel) | 2023 | 37296866 | PubTator, text mining | PubMed |
| Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer. | Cell Death Dis | 2023 | 37291119 | PubTator, text mining | PubMed |
| Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade. | J Immunother Cancer | 2023 | 37277193 | PubTator, text mining | PubMed |
| Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy. | Front Nutr | 2023 | 37275637 | PubTator, text mining | PubMed |
| PRC2 direct transfer from G-quadruplex RNA to dsDNA has implications for RNA-binding chromatin modifiers. | Proc Natl Acad Sci U S A | 2023 | 37252986 | PubTator, text mining | PubMed |
| EWSR1 maintains centromere identity. | Cell Rep | 2023 | 37243594 | PubTator, text mining | PubMed |
| RETRO-TAS, a Retrospective Observational Study of Trifluridine/Tipiracil in Chemorefractory Metastatic Colorectal Cancer. | Biomedicines | 2023 | 37238938 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=17